Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akitsu Hotta

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
Cell Stem Cell|January 21, 2020
Tissue-Engineered Vascular Grafts with Advanced Mechanical Strength from Human iPSCsJiesi Luo, Lingfeng Qin, Liping Zhao, et al.
Clinical Science (London, England : 1979)|February 20, 2019
<i>MiR-33a</i> is a therapeutic target in SPG4-related hereditary spastic paraplegia human neuronsFumiko Nakazeki, Itaru Tsuge, Takahiro Horie, et al.
Biochemical and Biophysical Research Communications|February 21, 2018
Human AK2 links intracellular bioenergetic redistribution to the fate of hematopoietic progenitorsKoichi Oshima, Norikazu Saiki, Michihiro Tanaka, et al.
Nature Communications|March 15, 2020
Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skippingPeter Gee, Mandy S Y Lung, Yuya Okuzaki, et al.
Science Translational Medicine|May 26, 2017
The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosisKeiko Imamura, Yuishin Izumi, Akira Watanabe, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
Cell Stem Cell|January 21, 2020
Tissue-Engineered Vascular Grafts with Advanced Mechanical Strength from Human iPSCsJiesi Luo, Lingfeng Qin, Liping Zhao, et al.
Clinical Science (London, England : 1979)|February 20, 2019
<i>MiR-33a</i> is a therapeutic target in SPG4-related hereditary spastic paraplegia human neuronsFumiko Nakazeki, Itaru Tsuge, Takahiro Horie, et al.
Biochemical and Biophysical Research Communications|February 21, 2018
Human AK2 links intracellular bioenergetic redistribution to the fate of hematopoietic progenitorsKoichi Oshima, Norikazu Saiki, Michihiro Tanaka, et al.
Nature Communications|March 15, 2020
Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skippingPeter Gee, Mandy S Y Lung, Yuya Okuzaki, et al.
Science Translational Medicine|May 26, 2017
The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosisKeiko Imamura, Yuishin Izumi, Akira Watanabe, et al.
Pageof 10